SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001169245-21-000035
Filing Date
2021-05-13
Accepted
2021-05-13 16:14:46
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q phas-20210331.htm   iXBRL 10-Q 1276805
2 EX-10.2 ex102-phas10xq2021q1.htm EX-10.2 297971
3 EX-31.1 ex311-phas10xq2021q1.htm EX-31.1 10249
4 EX-31.2 ex312-phas10xq2021q1.htm EX-31.2 10243
5 EX-32.1 ex-321xphas10xq2021q1.htm EX-32.1 4745
6 EX-32.2 ex-322xphas10xq2021q1.htm EX-32.2 4745
  Complete submission text file 0001169245-21-000035.txt   5411044

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20210331.xsd EX-101.SCH 42516
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phas-20210331_cal.xml EX-101.CAL 62852
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phas-20210331_def.xml EX-101.DEF 180280
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20210331_lab.xml EX-101.LAB 486448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20210331_pre.xml EX-101.PRE 299692
12 EXTRACTED XBRL INSTANCE DOCUMENT phas-20210331_htm.xml XML 577367
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 21919800
SIC: 2834 Pharmaceutical Preparations